首頁 > 市場調查報告書 > 醫療設備

避孕器市場規模、佔有率和成長分析（按產品類型、技術、分銷管道和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1896838

避孕器市場規模、佔有率和成長分析（按產品類型、技術、分銷管道和地區分類）－2026-2033年產業預測

Contraceptive Devices Market Size, Share, and Growth Analysis, By Product Type, By Technology, By Distribution Channel, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月17日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，避孕器市場規模將達到 318.3 億美元，到 2025 年將達到 337.6 億美元，到 2033 年將達到 540.5 億美元，在預測期（2026-2033 年）內，複合年成長率為 6.06%。

由於各方努力減少意外懷孕和醫療費用，以及使用者意識的提高，避孕器市場預計將會成長。政府和醫療機構主導的各項計劃旨在推廣計劃生育，並加強避孕器的生產和分銷。私營部門和公共部門都對避孕器供應鏈做出了重要貢獻，其中私營部門主要專注於避孕套和避孕藥等短效避孕方法，佔據了相當大的市場佔有率。在某些地區，相當一部分女性從私人機構取得避孕器，而其他女性則依賴公共服務。青少年的綜合性宣傳活動和教育計畫對於推廣避孕器、預防性性行為感染和意外懷孕至關重要，並得到了許多知名健康組織的大力支持。

避孕器市場促進因素

避孕器市場的一項重大進展是高效無激素避孕器（IUD）的問世。這項創新技術為女性提供可靠且持久的避孕方式。 IUD採用獨特的設計，注重安全性和易用性，確保了無痛的避孕體驗，同時降低了副作用的風險。其高效性和易用性使其成為尋求便捷可靠避孕方式的女性的理想選擇。這項進展標誌著生殖健康選擇範圍擴大，以滿足世界各地女性多樣化需求和偏好的重要轉折點。

避孕器市場限制

避孕器市場面臨一些挑戰，這些挑戰可能會阻礙其成長潛力。成本上升、某些器械可能引發的併發症以及地區監管差異等因素可能會限制避孕產品的可及性和消費者接受度。此外，文化偏見和關於生殖健康的誤解可能會阻礙人們尋求這些選擇。某些族群對避孕的抗拒也可能影響市場接受度。此外，其他避孕方法的普及可能會加劇市場競爭，因此，持續創新和消費者教育對於製造商保持強大的市場地位至關重要。

避孕器市場趨勢

避孕器市場受多種因素影響顯著成長，包括意外懷孕率上升和人們對計劃生育方法的認知提高。性行為感染感染（STI）的日益普及以及政府對計劃生育舉措的大力支持進一步推動了市場擴張。從保險套到長效植入多種避孕方法的普及，加上可支配收入的增加，提高了避孕產品的可近性。此外，電子商務平台的蓬勃發展、創新避孕方案的研發以及消費者對非荷爾蒙和自然避孕方法的偏好轉變（尤其是那些顯著偏向女性的主導方法），都反映了消費者偏好的變化，並有效地推動了市場發展。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2021-2023年營收年比比較

主要企業簡介

Bayer AG（Germany）
Pfizer Inc.（US）
Janssen Global Services, LLC（US）
Teva Pharmaceutical Industries Ltd.（Israel）
Merck Sharp & Dohme Corp.（US）
Mylan NV（US）
Reckitt Benckiser Group plc.（UK）
Veru Inc.（US）
Medisafe Distribution Inc.（Canada）
CooperSurgical, Inc.（US）
Devex（US）
Mayer Laboratories, Inc.（US）
Allergan plc（Ireland）
Agile Therapeutics（US）
HLL Lifecare（India）
Ansell Ltd（Australia）
Mankind Pharma（India）
TTK HealthCare（India）
Boehringer Ingelheim International GmbH.（Germany）
V-Care Pharma Pvt. Ltd.（India）

結論與建議

簡介目錄

Product Code: SQMIG35I2253

Contraceptive Devices Market size was valued at USD 31.83 Billion in 2024 and is poised to grow from USD 33.76 Billion in 2025 to USD 54.05 Billion by 2033, growing at a CAGR of 6.06% during the forecast period (2026-2033).

The contraceptive devices market is set to experience growth driven by initiatives aimed at minimizing unintended pregnancies and healthcare expenditures while increasing user awareness. Various programs led by governments and healthcare organizations advocate for family planning and enhance the production and distribution of contraceptives. Both private and public sectors significantly contribute to the contraceptive supply chain, with the private sector focusing on short-acting methods such as condoms and pills, capturing a substantial market share. In certain regions, a notable percentage of women source contraceptives from private providers, while others depend on public services. Comprehensive campaigns and educational programs targeting younger demographics are crucial for promoting contraceptive use and preventing both STDs and unintended pregnancies, supported by vital contributions from renowned health organizations.

Top-down and bottom-up approaches were used to estimate and validate the size of the Contraceptive Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Contraceptive Devices Market Segments Analysis

Global Contraceptive Devices Market is segmented by product type, technology, distribution channel and region. Based on product type, the market is segmented into male contraceptive devices, female contraceptive devices, female condoms, diaphragms & sponges, vaginal rings, intrauterine devices, sub-dermal implants and others. Based on technology, the market is segmented into hormonal contraceptives and barrier contraceptives. Based on distribution channel, the market is segmented into hospital pharmacy, retail pharmacy, clinics, online channels, public channel & ngo and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Contraceptive Devices Market

A significant advancement in the contraceptive devices market is the introduction of a highly efficient, non-hormonal intrauterine device (IUD). This innovative technology presents women with a dependable and enduring form of birth control. Featuring a unique design that emphasizes safety and user-friendliness, this IUD ensures a seamless contraceptive experience while reducing the likelihood of side effects. Its effectiveness and ease of use position it as an attractive option for women in search of convenient and reliable contraception. This development represents a pivotal shift toward more options in reproductive health, catering to the diverse needs and preferences of women worldwide.

Restraints in the Contraceptive Devices Market

The Contraceptive Devices market faces certain challenges that can hinder its growth potential. Factors such as rising costs, potential complications associated with some devices, and varying regulations across different regions can limit accessibility and consumer adoption. Additionally, cultural stigmas and misinformation surrounding reproductive health may discourage individuals from seeking out these options. Resistance from certain groups, who may view contraceptive use unfavorably, can also impact market acceptance. Furthermore, the availability of alternative birth control methods may lead to increased competition, making it essential for manufacturers to continuously innovate and educate consumers to maintain a strong foothold in the market.

Market Trends of the Contraceptive Devices Market

The Contraceptive Devices market is experiencing significant growth driven by various factors, including rising rates of unintended pregnancies and a growing awareness of family planning methods. Increased prevalence of sexually transmitted infections (STIs) and heightened governmental support for family planning initiatives further catalyze market expansion. The diverse availability of contraceptive options, ranging from condoms to long-acting implants, along with rising disposable incomes, enhances accessibility. Additionally, the surge in e-commerce platforms, development of innovative contraceptive solutions, and a noticeable shift towards non-hormonal and natural methods reflect evolving consumer preferences, particularly towards female-controlled options, effectively propelling the market forward.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Analysis
Patent Analysis
Case Study Analysis
Startup Analysis

Global Contraceptive Devices Market Size by Product Type & CAGR (2026-2033)

Market Overview
Male Contraceptive Devices
Female Contraceptive Devices
Female Condoms, Diaphragms & Sponges
Vaginal Rings
Intrauterine Devices
Sub-Dermal Implants
Others

Global Contraceptive Devices Market Size by Technology & CAGR (2026-2033)

Market Overview
Hormonal Contraceptives
Barrier Contraceptives

Global Contraceptive Devices Market Size by Distribution Channel & CAGR (2026-2033)

Market Overview
Hospital Pharmacy
Retail Pharmacy
Clinics
Online Channels
Public Channel & Ngo
Others

Global Contraceptive Devices Market Size & CAGR (2026-2033)

North America (Product Type, Technology, Distribution Channel)
- USA
- Canada
Europe (Product Type, Technology, Distribution Channel)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Technology, Distribution Channel)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Technology, Distribution Channel)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Technology, Distribution Channel)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Bayer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Janssen Global Services, LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Pharmaceutical Industries Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck Sharp & Dohme Corp. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mylan N.V. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Reckitt Benckiser Group plc. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Veru Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medisafe Distribution Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CooperSurgical, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Devex (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mayer Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Allergan plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agile Therapeutics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HLL Lifecare (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ansell Ltd (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mankind Pharma (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TTK HealthCare (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boehringer Ingelheim International GmbH. (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
V-Care Pharma Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments